Serum macrophage migration inhibition factor for diagnosing endometriosis and its severity: case-control study
- PMID: 32883256
- PMCID: PMC7469285
- DOI: 10.1186/s12905-020-01051-0
Serum macrophage migration inhibition factor for diagnosing endometriosis and its severity: case-control study
Abstract
Background: Endometriosis is a long-standing progressive disease that affects women of reproductive age. Macrophage migration inhibitory factor (MIF) is one of non-invasive blood biomarker that was detected in sera of endometriotic patients. The present study aimed to determine the accuracy of serum MIF in diagnosing endometriosis in women with infertility and chronic pelvic pain, and correlate its level to the stage of the disease.
Methods: Observational case-control study conducted at Fayoum University hospital from March 2016 till September 2018. Three hundred women candidate for diagnostic laparoscopy for either infertility or gynecologic chronic pelvic pain were included. The study group included patients with symptoms suggestive of endometriosis or chocolate cyst by ultrasound and proved by laparoscopy and histopathology. The control group included other causes of infertility or pelvic pain. All patients undergone either diagnostic or operative laparoscopy, and before laparoscopy blood sampling for quantitative measurement of macrophage migration inhibitory factor (MIF) protein in serum by ELISA technique.
Results: The level of serum MIF was significantly higher in endometriosis group compared to control group (1.75 ± 1.48 pg/ml and 0.51 ± 0.45 pg/ ml, respectively, P = < 0.001), with a progressive increase with advancing stage (stage I, 1.3 ± 1.03 pg/ml, stage II, 1.7 ± 1.57 pg/ml, stage III, 2.1 ± 1.19 pg/ml and in stage IV, 3.2 ± 2.6 pg/ml). Moreover, in patients presented with pain and infertile patients showed significantly higher levels of serum MIF (1.92 ± 1.13 vs 1.21 ± 1.17 and 1.82 ± 1.13 vs 1.32 ± 0.91 respectively with p-value < 0.001). ROC curve of serum MIF with a cut off value of 0.85 pg/ml or more achieves a sensitivity of 80.6%, specificity of 83.3%, positive predictive value of 82.9% and negative predictive value of 81.2%.
Conclusion: Serum MIF might be a promising marker not only for noninvasive diagnosis of endometriosis but as a target for detecting severity as well.
Keywords: Chronic pelvic pain; Diagnosis; Endometriosis; Infertility; Laparoscopy; Serum macrophage migration inhibition factor.
Conflict of interest statement
Authors decline any relevant financial, personal, political, intellectual, or religious interests.
Similar articles
-
Elevated levels of macrophage migration inhibitory factor in the peripheral blood of women with endometriosis.Fertil Steril. 2005 Apr;83(4):865-72. doi: 10.1016/j.fertnstert.2004.10.039. Fertil Steril. 2005. PMID: 15820792
-
Serum galectin-9 as a noninvasive biomarker for the detection of endometriosis and pelvic pain or infertility-related gynecologic disorders.Fertil Steril. 2017 Dec;108(6):1016-1025.e2. doi: 10.1016/j.fertnstert.2017.09.008. Fertil Steril. 2017. PMID: 29202955
-
Soluble Factors CD14, CD163, and Migration Inhibitory Factor Are Associated with Endometriosis-Related Infertility.Gynecol Obstet Invest. 2024;89(4):335-345. doi: 10.1159/000538525. Epub 2024 Apr 3. Gynecol Obstet Invest. 2024. PMID: 38569489
-
[Minimal and mild endometriosis: Impact of the laparoscopic surgery on pelvic pain and fertility. CNGOF-HAS Endometriosis Guidelines].Gynecol Obstet Fertil Senol. 2018 Mar;46(3):273-277. doi: 10.1016/j.gofs.2018.02.004. Epub 2018 Mar 3. Gynecol Obstet Fertil Senol. 2018. PMID: 29510965 Review. French.
-
The laparoscopic management of endometriosis in patients with pelvic pain.Obstet Gynecol Clin North Am. 2014 Sep;41(3):371-83. doi: 10.1016/j.ogc.2014.05.002. Epub 2014 Jul 9. Obstet Gynecol Clin North Am. 2014. PMID: 25155119 Review.
Cited by
-
Peritoneal immune microenvironment of endometriosis: Role and therapeutic perspectives.Front Immunol. 2023 Feb 14;14:1134663. doi: 10.3389/fimmu.2023.1134663. eCollection 2023. Front Immunol. 2023. PMID: 36865552 Free PMC article. Review.
-
Disease Severity- and Hormonal Status-Dependent Alterations of EGF and MIF in the Serum of Endometriosis Patients.Int J Mol Sci. 2025 Jul 12;26(14):6695. doi: 10.3390/ijms26146695. Int J Mol Sci. 2025. PMID: 40724945 Free PMC article.
-
Inflammatory MicroRNAs and the Pathophysiology of Endometriosis and Atherosclerosis: Common Pathways and Future Directions Towards Elucidating the Relationship.Reprod Sci. 2022 Aug;29(8):2089-2104. doi: 10.1007/s43032-022-00955-6. Epub 2022 Apr 27. Reprod Sci. 2022. PMID: 35476352 Review.
-
Identification and validation of immune-related and inflammation-related genes in endometriosis.Front Endocrinol (Lausanne). 2025 May 8;16:1545670. doi: 10.3389/fendo.2025.1545670. eCollection 2025. Front Endocrinol (Lausanne). 2025. PMID: 40405976 Free PMC article.
-
Endometriosis: An Immunologist's Perspective.Int J Mol Sci. 2025 May 28;26(11):5193. doi: 10.3390/ijms26115193. Int J Mol Sci. 2025. PMID: 40508002 Free PMC article. Review.
References
-
- Rakhila H, Girard K, Leboeuf M, Lemyre M, Akoum A. Macrophage migration inhibitory factor is involved in ectopic endometrial tissue growth and peritoneal-endometrial tissue interaction in vivo: a plausible link to endometriosis development. PLoS One. 2014;9(10):e110434. doi: 10.1371/journal.pone.0110434. - DOI - PMC - PubMed
-
- Scioscia M, Bruni F, Ceccaroni M, Steinkasserer M, Stepniewska A, Minelli L. Distribution of endometriotic lesions in endometriosis stage IV supports the menstrual reflux theory and requires specific preoperative assessment and therapy. Acta Obstet Gynecol Scand. 2011;90(2):136–139. doi: 10.1111/j.1600-0412.2010.01008.x. - DOI - PubMed
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous